Nebius Inc. (NASDAQ: NBIS) soared 17% on Monday after Goldman Sachs initiated coverage with a "Buy" rating and a $68 price target — implying roughly 39% upside from current levels. The investment bank values the AI-focused Neocloud provider at approximately $10.5...
Nebius Stock Jumps After Goldman Sachs Initiates Coverage
Nebius Inc. (NASDAQ: NBIS) soared 17% on Monday after Goldman Sachs initiated coverage with a "Buy" rating and a $68 price target — implying roughly 39% upside from current levels. The investment bank values the AI-focused Neocloud provider at approximately $10.5...
CoreWeave Stock Soars Amid Data Center Expansion in Texas, Spotlighting AI’s Power Strain
CoreWeave Inc. (NASDAQ: CORZR) surged 33% following news of a major data center expansion in Denton, Texas — a development that underscores the growing strain artificial intelligence (AI) is placing on America’s power grid. The new facility, which is being developed...
Ultragenyx (RARE) Stock Sinks 25%
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is taking a sharp hit in premarket trading Thursday, with shares falling as much as 25% after the company delivered an underwhelming clinical trial update late Wednesday. The news centered around its late-stage trial of...